Neonc Technologies (NTHI) Expected to Announce Quarterly Earnings on Friday

Neonc Technologies (NASDAQ:NTHI) is expected to post its results before the market opens on Friday, February 20th. Analysts expect Neonc Technologies to post earnings of ($0.37) per share for the quarter.

Neonc Technologies Price Performance

NASDAQ:NTHI opened at $9.26 on Wednesday. The stock has a 50-day simple moving average of $9.10 and a two-hundred day simple moving average of $8.87. Neonc Technologies has a 52-week low of $3.20 and a 52-week high of $25.00.

Insider Buying and Selling at Neonc Technologies

In other news, President Amir F. Heshmatpour bought 24,000 shares of Neonc Technologies stock in a transaction dated Friday, November 21st. The shares were purchased at an average cost of $6.07 per share, with a total value of $145,680.00. Following the completion of the acquisition, the president owned 2,986,000 shares of the company’s stock, valued at $18,125,020. This trade represents a 0.81% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders bought a total of 31,100 shares of company stock worth $192,099 in the last ninety days.

Hedge Funds Weigh In On Neonc Technologies

Several institutional investors have recently added to or reduced their stakes in NTHI. Bank of America Corp DE increased its stake in Neonc Technologies by 1.0% in the 3rd quarter. Bank of America Corp DE now owns 226,486 shares of the company’s stock worth $2,056,000 after acquiring an additional 2,207 shares during the last quarter. State Street Corp grew its holdings in shares of Neonc Technologies by 9.9% in the fourth quarter. State Street Corp now owns 43,170 shares of the company’s stock valued at $357,000 after purchasing an additional 3,900 shares in the last quarter. Barclays PLC increased its position in Neonc Technologies by 5,314.8% in the fourth quarter. Barclays PLC now owns 9,151 shares of the company’s stock worth $76,000 after purchasing an additional 8,982 shares during the last quarter. Goldman Sachs Group Inc. bought a new stake in Neonc Technologies in the fourth quarter worth $124,000. Finally, OMERS ADMINISTRATION Corp purchased a new stake in Neonc Technologies during the fourth quarter valued at $126,000.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on NTHI. Weiss Ratings reiterated a “sell (e+)” rating on shares of Neonc Technologies in a research note on Monday, December 29th. Zacks Research upgraded shares of Neonc Technologies to a “hold” rating in a research report on Wednesday, January 14th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Reduce”.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.